Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer

Author： Msaouel Pavlos   Nandikolla Gayathri   Pneumaticos Spyros G   Koutsilieris Michael  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.11, 2013-11, pp. : 1385-1400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 16-22

Bentham Science Publishers

Access to resources Recommend Favorite

Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)

By Mitsogiannis Iraklis C   Skolarikos Andreas   Deliveliotis Charalambos  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 3, 2009-02 ,pp. : 493-501

Informa Healthcare

Access to resources Recommend Favorite

New agents and strategies for the hormonal treatment of castration-resistant prostate cancer

By Sharifi Nima  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 837-846

Informa Healthcare

Access to resources Recommend Favorite

Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer

By Twiddy Alexis   Leon Carlos   Wasan Kishor  

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 423-437

Springer Publishing Company

Access to resources Recommend Favorite